Continuing InteliCare’s push to list on the ASX during the COVID-19 pandemic, lead manager, JP Equity, sent the allocations for the $5.5 million offer.
As confidence in duress pendants decreases, InteliCare offers a reliable health & wellbeing solution to support seniors living at home.
InteliCare’s CEO Jason Waller joins a routable of experts in aged care, medtech, and care tech discuss a range of topics to discuss increased funding.
InteliCare is uniquely positioned to help aging Australians that want to avoid full time aged care facilities but are still on the waiting list to receive a Home Care Package from My Aged Care.
The Sydney Morning Herald spoke with InteliCare CEO and Managing Director, Jason Waller, to discuss InteliCare’s momentum on the back of the coronavirus pandemic.
On the back of the COVID-19 (coronavirus) outbreak that is happening worldwide, Stockhead took a look at the Australian medical technology companies that are well placed to benefit from the increase in medtech and telehealth demand.
The Australian Financial Review takes a look at InteliCare’s initial public offering (IPO) and why it could be one of the only companies not pausing its run.
Stockhead: JP Equity Partners on the potential for new tech solutions to disrupt Australian aged care market
Stockhead sat down with Nic Brownbill, a director at investment and advisory firm JP Equity Partners to discuss how private businesses, and InteliCare specifically, will play a role in meeting the demand.